Nxstage Medical, Inc. (NXTM) Posts Q3 Loss of 8c/Share; Cuts FY13 Outlook
Tweet Send to a Friend
Nxstage Medical, Inc. (NASDAQ: NXTM) reported Q3 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
